Kennebec Savings Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$109K Hold
1,200
0.09% 124
2026
Q1
$96.1K Hold
1,200
0.09% 112
2025
Q4
$102K Hold
1,200
0.09% 110
2025
Q3
$93.3K Hold
1,200
0.09% 111
2025
Q2
$93.9K Hold
1,200
0.09% 113
2025
Q1
$87K Hold
1,200
0.09% 115
2024
Q4
$85.3K Hold
1,200
0.09% 118
2024
Q3
$79.2K Buy
+1,200
New +$87.2K 0.08% 123

Other funds holding EW

Kennebec Savings Bank's EW Position: Q2 2026 in Review

Kennebec Savings Bank held its Edwards Lifesciences (EW) position steady in Q2 2026 at 1,200 shares worth $109K. The position accounts for 0.09% of the portfolio, ranked #124.

Kennebec Savings Bank first reported a position in EW in Q3 2024 and has held it in 8 quarters since. 421 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Kennebec Savings Bank held 1,200 shares of Edwards Lifesciences worth $109K as of Q2 2026.
  • Kennebec Savings Bank left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.09% of Kennebec Savings Bank's portfolio in Q2 2026, its #124 holding.
  • Kennebec Savings Bank first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 8 quarters since.
  • 421 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Kennebec Savings Bank's 13F filing for Q2 2026, filed 13 Jul 2026.